Share

April 2016; 6 (2) Editorial

Serum prolactin in seizure diagnosis

Glass half-full or half-empty?

Robert S. Fisher
First published March 8, 2016, DOI: https://doi.org/10.1212/CPJ.0000000000000228
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1349

Share

Article Information

vol. 6 no. 2 100-101
DOI: 
https://doi.org/10.1212/CPJ.0000000000000228
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • First Published March 8, 2016.

Article Versions

Copyright & Usage: 
© 2016 American Academy of Neurology

Author Disclosures

    1. Robert S. Fisher, MD, PhD
  1. Robert S. Fisher, MD, PhD
    2. Scientific Advisory Boards:

    1. 1. Nonprofit: Epilepsy Foundation of Northern California 2. Commercial: Zeto, Inc. (dry EEG) 3. Commercial: Advanced Neurometrics, Inc. (dry EEG) 4. Commercial: Avails Medical, Inc. (drug levels)

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. Method for measuring drug levels in saliva

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. 1. Commercial: ICVRx (CSF drug infusion) 2. Commercial: Zeto, Inc.

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. 1. Commercial: Medtronic to Stanford University for DBS

    Research Support, Government Entities:

    1. NSF, IIP-1430833-Stanford, SBIR Phase II: Innovative Electroencephalography to Advance the Research and Diagnosis of Brain Disorders, role is co-PI, 10/01/2014 to 09/30/2016.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Epilepsy Foundation to Stanford University for a study of Seizure Clustering

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. ICVRx, 2010-2015 Avails Medical 2012-2015 SmartMonitor 2005-2015

    Legal Proceedings:

    1. NONE

  1. Stanford University School of Medicine, Stanford, CA.
  1. Correspondence to:
    robert.fisher{at}stanford.edu
View Full Text

Article usage

Article usage: March 2016 to December 2021

AbstractFullPdfSource
Mar 201611327Highwire
Apr 20162982137Highwire
May 201611649Highwire
Jun 20167917Highwire
Jul 20164201Highwire
Aug 20164208Highwire
Sep 20164504Highwire
Oct 20164302Highwire
Nov 20163032Highwire
Dec 20163610Highwire
Jan 20174800Highwire
Feb 20172301Highwire
Mar 20173500Highwire
Apr 20171902Highwire
May 20172700Highwire
Jun 20172901Highwire
Jul 20172301Highwire
Aug 20171100Highwire
Sep 20171602Highwire
Oct 20172300Highwire
Nov 20173820Highwire
Dec 20174422Highwire
Jan 20184700Highwire
Feb 20188100Highwire
Mar 20184632Highwire
Apr 20187300Highwire
Apr 201814250275pmc
May 20184200Highwire
Jun 20184201Highwire
Jun 201814329369pmc
Jul 20187800Highwire
Aug 20184300Highwire
Aug 201825500585pmc
Sep 20184712Highwire
Oct 20184600Highwire
Nov 20184710Highwire
Dec 20184410Highwire
Jan 20193811Highwire
Feb 20191900Highwire
Mar 20194100Highwire
Apr 20193311Highwire
May 20193000Highwire
Jun 20193141Highwire
Jul 20193010Highwire
Aug 20192821Highwire
Sep 20193122Highwire
Oct 20194754Highwire
Nov 20195112Highwire
Dec 20195110Highwire
Jan 20206321Highwire
Feb 20209610Highwire
Mar 20208410Highwire
Apr 20209720Highwire
May 202010510Highwire
Jun 20207773Highwire
Jul 20206471Highwire
Aug 20206770Highwire
Sep 20206170Highwire
Oct 202012730Highwire
Nov 202013371Highwire
Dec 20209771Highwire
Jan 202114460Highwire
Feb 20219942Highwire
Mar 202116961Highwire
Apr 202112040Highwire
May 20217542Highwire
Jun 202114752Highwire
Jul 202110821Highwire
Aug 202110031Highwire
Sep 202110330Highwire
Oct 20219040Highwire
Nov 20218060Highwire
Dec 20217831Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me